top of page

Here's what's happening in New Jersey...
Search


Building a Better Mouse Model for Mycobacterium abscessus: Julianna Proietto’s Innovations in Chronic Infection Research
At the 2025 Theobald Smith Society Spring Symposium, Julianna Proietto, Senior Animal Specialist at the Center for Discovery and...

Ray Sullivan
May 142 min read
154
0


Honoring Innovation and Resilience: Dr. Jason Yang Receives the 2025 Theobald Smith Young Investigator Award
The Theobald Smith Society is proud to present the 14th Young Investigator Award to Dr. Jason H. Yang, Assistant Professor and Chancellor...

Ray Sullivan
May 142 min read
73
0


Is There a Histone Code in Bacteria? Valerie Carabetta’s Search for Epigenetic Regulation in Bacillus subtilis
At the 2025 Theobald Smith Society Spring Symposium, Valerie Carabetta —Associate Professor at Cooper Medical School of Rowan...

Ray Sullivan
May 143 min read
18
1


Microbes Below and Above: Donna Fennell’s Legacy of Remediation Science
At the 2025 Theobald Smith Society Spring Symposium, Professor Donna Fennell, Chair of the Department of Environmental Sciences at...

Ray Sullivan
May 134 min read
29
1


Understanding the Hidden Epidemic: Drug-Resistant Klebsiella in the Community
At the 2025 Theobald Smith Society Spring Symposium, the society president, Jennifer Sun, introduced Professor Barry Kreiswirth , the...

Ray Sullivan
May 125 min read
50
1


Rutgers: Electrospray Coating Microneedles for DNA Vaccine Delivery
Microneedle arrays are a minimally invasive and promising alternative to traditional hypodermic needles for drug and vaccine delivery. ...

Ray Sullivan
May 52 min read
10
0


CDI: Next-Generation Rifamycins for Mycobacterial Infections
Mycobacterium abscessus is a rapidly growing non-tuberculous Mycobacterium causing severe pulmonary infections, especially in...

Ray Sullivan
May 42 min read
89
1


CDI: C. auris Gcn5: Drug Resistance, Virulence, and Therapy Target
The human infectious fungus Candida auris poses a significant global human health burden. C. auris is classified as an urgent threat...

Ray Sullivan
May 11 min read
292
0


Quest: US Hepatitis Delta Burden
Quest Diagnostics Inc., Secaucus, NJ investigated the prevalence of Hepatitis Delta Virus (HDV) infection in the United States among...

Ray Sullivan
Apr 302 min read
13
0


Merck: Adult Pneumococcal Vaccine V116: Impact and Coverage
Scientists from Merck, Rahway, NJ, evaluated the potential impact of their novel adult-specific pneumococcal conjugate vaccine, V116, on...

Ray Sullivan
Apr 251 min read
4
0


Princeton: Worm Learns Pathogen Avoidance from Bacteria
Coleen Murphy’s lab at Princeton seeks to find genes that contribute to maintaining the biological processes that exhibit age-related...

Ray Sullivan
Apr 242 min read
24
0


Princeton: Yeast Fermentation Enhanced by Light-Controlled Nanobody Inhibition
Transcriptional control is widely used in dynamic metabolic engineering, but it suffers from inherent time lags because existing...

Ray Sullivan
Apr 192 min read
8
0


Shionogi: US Hospital Burden of Carbapenem-Resistant Acinetobacter baumannii (CRAB)
This retrospective cohort study undertaken by Shionogi, Inc., Florham Park, NJ , analyzed data from the PINC AI™ Database between January...

Ray Sullivan
Apr 181 min read
9
0


Merck: HDC-MALS for Pneumococcal Conjugate Vaccine Characterization
Invasive pneumococcal diseases remain a major global health concern. Pneumococcal capsular polysaccharides are key immunogenic...

Ray Sullivan
Apr 171 min read
1
0


Rutgers: HIV Hide and Seek
HIV persists in latently infected memory CD4+ T cells despite effective antiretroviral therapy, leading to rapid viral rebound upon...

Ray Sullivan
Apr 172 min read
12
0


IAVI: Lassa Virus Vaccine Development
Lassa fever is a serious zoonotic hemorrhagic disease caused by the Lassa virus, an enveloped RNA virus in the Arenaviridae family. It is...

Ray Sullivan
Apr 133 min read
3
0


HMH-CDI: Oral Triple Therapy for Mycobacterium abscessus
Researchers at the Center for Discovery & Innovation, Nutley, NJ, investigated a novel oral drug combination of tebipenem-avibactam,...

Ray Sullivan
Apr 121 min read
47
0


ASM Expands Open Access
The American Society for Microbiology (ASM) has achieved its sustainability target for the 2025 subscription year under the Subscribe to...

Ray Sullivan
Apr 111 min read
2
0


Princeton: Pathogen Immune-Escape Dynamics
Bjarke F. Nielsen and colleagues at Princeton introduce a mathematical framework to understand how pathogen evolution, specifically...

Ray Sullivan
Apr 41 min read
2
0


Merck: Pneumococcal Vaccination, a US Dynamic Transmission Model
Merck & Co., Rahway, NJ, developed a dynamic transmission model to assess the impact of pneumococcal vaccination strategies in the United...

Ray Sullivan
Apr 31 min read
1
0
bottom of page